Vitasora Health (ASX: VHL) has completed the implementation of its proprietary vCare electronic medical record platform across its chronic care management business.
The roll-out gives the company a unified operating platform designed to improve patient enrolment, workforce flexibility, engagement, and reimbursement integrity.
The remote patient monitoring (RPM) module has also been completed and is undergoing final live operational testing ahead of a planned 1 July 2026 launch.
The platform transition is expected to reduce software costs by more than 90% and support about $1.7 million to $1.8m in annualised savings.
Scalable Internal System
Vitasora implemented vCare from 1 April 2026 in line with the operational milestones outlined in its March quarterly activities report.
The platform has allowed patient operations and workflows to move onto a scalable internal system across the chronic care management business, and Vitasora expects the completed RPM module enable it to transition fully from the legacy Ceras platform.
That transition is designed to improve workflow efficiency, data integrity, and continuity of Centres for Medicare & Medicaid Services reimbursement capture for clients and patients.
Vitasora expects to realise the full financial benefits of the vCare transition from July 2026, with software platform costs expected to fall from about $7 to less than $1 per patient per month, generating annualised software-as-a-service (SaaS) savings of about $720,000 for every 10,000 active patients.
Combined with workflow automation, better workforce use and lower reliance on third-party platforms, the company expects total annualised operating efficiencies of about $1.7m to $1.8m.
Enrolment Acceleration
Vitasora’s previously disclosed opportunity across about 40,000 existing client patients has entered an active enrolment acceleration phase after the company deliberately moderated enrolment during the March quarter to support platform optimisation and workflow refinement.
April enrolments reached 469 patients, almost double the February and March monthly averages.
Momentum has continued into May, with 163 patients enrolled during the first seven billing days of the month, implying a monthly run-rate above 550 enrolments and growth of more than 130% compared with February and March.
At average fee-for-service revenue of about $85 per patient per month, the company estimates that 6,500 billed fee-for-service patients would support monthly revenue of about $550,000.
When combined with existing UPEC call centre services and TCM/PMPM revenue streams, that level would imply an estimated monthly revenue run-rate of about $650,000.
Monthly Profitability Targeted
Vitasora’s current billed fee-for-service patient base is about 2,800 patients and the company remains focused on reaching targeted monthly business-as-usual profitability in the second half of calendar year 2026.
“The successful implementation of vCare marks a transformational milestone for Vitasora,” chief executive officer Marjan Mikel said.
“Importantly, we have now executed on the operational initiatives outlined in our March Quarterly update and are already seeing tangible acceleration in patient onboarding activity.”
“The completion of the RPM module positions us to fully transition from legacy systems while maintaining reimbursement integrity and continuity for our clients,” he added.
Further updates are expected as enrolment acceleration progresses and the RPM module moves into commercial launch.
